Glucocorticoids, such as prednisone and deflazacort, have been used to treat DMD, and their anti-inflammatory properties are thought to be associated with the inhibition of NF-κB or transrepression pathway (Biggar et al., 2006; Miyatake et al., 2016; Vandewalle et al., 2018). Here, NFKB1 is linked to Duchenne muscular dystrophy.